NHS watchdog removes life-extending blood cancer treatment

Blood cancer patients will no longer be able to receive a life-extending treatment after the NHS watchdog scrapped its use.
Yahoo

Survival time for incurable blood cancer almost doubles since 2005, study finds

People with a form of blood cancer are living almost twice as long on average compared to 20 years ago, according to a study. However, experts warned survival for multiple myeloma “remains ...
AOL

Blood cancer survival odds could be ‘doubled’ as bone marrow test trial is a success

Patients with a rare and aggressive type of blood cancer could soon have their chances of survival doubled as a groundbreaking trial to detect the disease earlier concludes. Scientists working on the ...
Fred Hutch

For many blood cancer patients, CAR T-cell therapy is game-changing

CAR T-cell therapy, which transforms patients’ own immune cells into cancer-fighting warriors, has revolutionized how physicians treat cancer, especially blood cancers. “These patients can be cured ...
STAT

GSK blood cancer therapy, once pulled from the market, is approved in the U.K.

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. GSK’s blood cancer drug Blenrep won regulatory approval in the U.K. on ...